238 related articles for article (PubMed ID: 35900229)
21. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
Portillo Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
J Clin Endocrinol Metab; 2014 Oct; 100(5):. PubMed ID: 25303488
[TBL] [Abstract][Full Text] [Related]
22. Plasma Bile Acids More Closely Align With Insulin Resistance, Visceral and Hepatic Adiposity Than Total Adiposity.
Bishay RH; Tonks KT; George J; Samocha-Bonet D; Meyerowitz-Katz G; Chisholm DJ; James DE; Greenfield JR
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1131-e1139. PubMed ID: 33347566
[TBL] [Abstract][Full Text] [Related]
23. Influence of adiposity, insulin resistance, and intrahepatic triglyceride content on insulin kinetics.
Smith GI; Polidori DC; Yoshino M; Kearney ML; Patterson BW; Mittendorfer B; Klein S
J Clin Invest; 2020 Jun; 130(6):3305-3314. PubMed ID: 32191646
[TBL] [Abstract][Full Text] [Related]
24. The association between visceral adipocyte hypertrophy and NAFLD in subjects with different degrees of adiposity.
Sun H; Fang D; Wang H; Wang J; Yuan Y; Huang S; Ma H; Gu T; Bi Y
Hepatol Int; 2023 Feb; 17(1):215-224. PubMed ID: 36071305
[TBL] [Abstract][Full Text] [Related]
25. Low level of adiponectin predicts the development of Nonalcoholic fatty liver disease: is it irrespective to visceral adiposity index, visceral adipose tissue thickness and other obesity indices?
Ebrahimi R; Shanaki M; Mohassel Azadi S; Bahiraee A; Radmard AR; Poustchi H; Emamgholipour S
Arch Physiol Biochem; 2022 Feb; 128(1):24-31. PubMed ID: 31482741
[TBL] [Abstract][Full Text] [Related]
26. Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism.
Musso G; Cassader M; De Michieli F; Rosina F; Orlandi F; Gambino R
Hepatology; 2012 Sep; 56(3):933-42. PubMed ID: 22684858
[TBL] [Abstract][Full Text] [Related]
27. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
28. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat.
Burgert TS; Taksali SE; Dziura J; Goodman TR; Yeckel CW; Papademetris X; Constable RT; Weiss R; Tamborlane WV; Savoye M; Seyal AA; Caprio S
J Clin Endocrinol Metab; 2006 Nov; 91(11):4287-94. PubMed ID: 16912127
[TBL] [Abstract][Full Text] [Related]
29. Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients.
D'Incao RB; Tovo CV; Mattevi VS; Borges DO; Ulbrich JM; Coral GP; Ramos MJ; Meinhardt NG
Obes Surg; 2017 Aug; 27(8):2151-2158. PubMed ID: 28281237
[TBL] [Abstract][Full Text] [Related]
30. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.
Ercin CN; Dogru T; Genc H; Celebi G; Aslan F; Gurel H; Kara M; Sertoglu E; Tapan S; Bagci S; Rizzo M; Sonmez A
Metab Syndr Relat Disord; 2015 Sep; 13(7):319-25. PubMed ID: 26011302
[TBL] [Abstract][Full Text] [Related]
31. Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease.
Maruszczak K; Radzikowski K; Schütz S; Mangge H; Bergsten P; Forslund A; Manell H; Pixner T; Ahlström H; Kullberg J; Mörwald K; Weghuber D
Front Endocrinol (Lausanne); 2022; 13():1004128. PubMed ID: 36133310
[TBL] [Abstract][Full Text] [Related]
32. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.
Smith GI; Shankaran M; Yoshino M; Schweitzer GG; Chondronikola M; Beals JW; Okunade AL; Patterson BW; Nyangau E; Field T; Sirlin CB; Talukdar S; Hellerstein MK; Klein S
J Clin Invest; 2020 Mar; 130(3):1453-1460. PubMed ID: 31805015
[TBL] [Abstract][Full Text] [Related]
33. Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease.
Cuthbertson DJ; Shojaee-Moradie F; Sprung VS; Jones H; Pugh CJ; Richardson P; Kemp GJ; Barrett M; Jackson NC; Thomas EL; Bell JD; Umpleby AM
Clin Sci (Lond); 2016 Jan; 130(2):93-104. PubMed ID: 26424731
[TBL] [Abstract][Full Text] [Related]
34. Relationship between visceral adipose tissue and adiponectin, inflammatory markers and thyroid hormones in obese males with hepatosteatosis and insulin resistance.
Ozcelik F; Yuksel C; Arslan E; Genc S; Omer B; Serdar MA
Arch Med Res; 2013 May; 44(4):273-80. PubMed ID: 23602473
[TBL] [Abstract][Full Text] [Related]
35. Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars.
Luukkonen PK; Sädevirta S; Zhou Y; Kayser B; Ali A; Ahonen L; Lallukka S; Pelloux V; Gaggini M; Jian C; Hakkarainen A; Lundbom N; Gylling H; Salonen A; Orešič M; Hyötyläinen T; Orho-Melander M; Rissanen A; Gastaldelli A; Clément K; Hodson L; Yki-Järvinen H
Diabetes Care; 2018 Aug; 41(8):1732-1739. PubMed ID: 29844096
[TBL] [Abstract][Full Text] [Related]
36. Adiponectin, a key adipokine in obesity related liver diseases.
Buechler C; Wanninger J; Neumeier M
World J Gastroenterol; 2011 Jun; 17(23):2801-11. PubMed ID: 21734787
[TBL] [Abstract][Full Text] [Related]
37. Epicardial adipose tissue and cardiometabolic risk factors in overweight and obese children and adolescents.
Schusterova I; Leenen FH; Jurko A; Sabol F; Takacova J
Pediatr Obes; 2014 Feb; 9(1):63-70. PubMed ID: 23504985
[TBL] [Abstract][Full Text] [Related]
38. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
[TBL] [Abstract][Full Text] [Related]
39. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
[TBL] [Abstract][Full Text] [Related]
40. A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease.
Pacifico L; Bonci E; Di Martino M; Versacci P; Andreoli G; Silvestri LM; Chiesa C
Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):734-41. PubMed ID: 26026214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]